• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

伊马替尼诱发的慢性髓性白血病患者视神经炎

Imatinib-induced optic neuritis in a patient of chronic myeloid leukemia.

作者信息

Govind Babu K, Attili Venkata Satya Suresh, Bapsy P P, Anupama G

机构信息

Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bangalore, 560 029, India.

出版信息

Int Ophthalmol. 2007 Feb;27(1):43-4. doi: 10.1007/s10792-007-9038-9. Epub 2007 Apr 5.

DOI:10.1007/s10792-007-9038-9
PMID:17410337
Abstract

Imatinib is presently the commonest prescribes drug for patients of chronic myelogenous leukemia (CML) in chronic phase (CP) worldwide. Its ocular side effects are little known. Optic neuritis caused by this drug has not been reported (Medline search). We describe perhaps the first case of optic neuritis caused by this drug.

摘要

伊马替尼目前是全球慢性期慢性髓性白血病（CML）患者最常用的处方药。其眼部副作用鲜为人知。该药物引起的视神经炎尚未见报道（医学文献数据库检索）。我们描述了可能是首例由该药物引起的视神经炎病例。

相似文献

1
Imatinib-induced optic neuritis in a patient of chronic myeloid leukemia.伊马替尼诱发的慢性髓性白血病患者视神经炎
Int Ophthalmol. 2007 Feb;27(1):43-4. doi: 10.1007/s10792-007-9038-9. Epub 2007 Apr 5.
2
Successful management of liver injury caused by imatinib mesylate in a patient with previously untreated chronic myelogenous leukemia in the chronic phase.甲磺酸伊马替尼所致肝损伤在一名未经治疗的慢性期慢性粒细胞白血病患者中的成功管理。
Leuk Lymphoma. 2006 Jul;47(7):1427-30. doi: 10.1080/10428190600593877.
3
Pigmentary changes in chronic myeloid leukemia patients treated with imatinib mesylate.接受甲磺酸伊马替尼治疗的慢性髓性白血病患者的色素沉着变化。
Ann Oncol. 2004 Feb;15(2):358-9. doi: 10.1093/annonc/mdh068.
4
Severe hepatic injury caused by imatinib mesylate administered for the treatment of chronic myeloid leukemia and the efficacy of prednisolone for its management.甲磺酸伊马替尼治疗慢性粒细胞白血病所致严重肝损伤及泼尼松龙对其的治疗效果。
Int J Hematol. 2005 Nov;82(4):343-6. doi: 10.1532/IJH97.05034.
5
Photosensitization in chronic myelogenous leukaemia patients treated with imatinib mesylate.甲磺酸伊马替尼治疗的慢性粒细胞白血病患者的光敏反应
Br J Haematol. 2003 Mar;120(6):1091-2. doi: 10.1046/j.1365-2141.2003.04208_3.x.
6
A patient of chronic myelogenous leukemia developing painful rash on feet.一名慢性粒细胞白血病患者足部出现疼痛性皮疹。
J Postgrad Med. 2012 Oct-Dec;58(4):331-4. doi: 10.4103/0022-3859.105489.
7
Interstitial pneumonitis during imatinib therapy.
Br J Haematol. 2004 May;125(4):420. doi: 10.1111/j.1365-2141.2004.04833.x.
8
Imatinib mesylate: a new pill for chronic myelogenous leukemia.
Cancer Pract. 2001 Sep-Oct;9(5):263-5. doi: 10.1046/j.1523-5394.2001.95003.x.
9
Unusual fluid retention with imatinib therapy for chronic myeloid leukemia.
Leuk Lymphoma. 2007 Jan;48(1):195-6. doi: 10.1080/10428190600923157.
10
Imatinib mesylate induced immune thrombocytopenia.
Leuk Lymphoma. 2007 Nov;48(11):2261-3. doi: 10.1080/10428190701615934.

引用本文的文献

1
Side Effects of Novel Anticancer Drugs on the Posterior Segment of the Eye: A Review of the Literature.新型抗癌药物对眼后段的副作用：文献综述
J Pers Med. 2024 Dec 19;14(12):1160. doi: 10.3390/jpm14121160.
2
Leukaemic Optic Neuropathy in a Patient with Treated Acute Lymphoblastic Leukaemia: Optical Coherence Tomography as an Aid to Diagnosis.一名接受过治疗的急性淋巴细胞白血病患者的白血病性视神经病变：光学相干断层扫描辅助诊断
Neuroophthalmology. 2024 Feb 8;48(5):352-359. doi: 10.1080/01658107.2024.2313579. eCollection 2024.
3
Neuro-ophthalmic complications of modern anti-cancer drugs.

本文引用的文献

1
High-dose imatinib mesylate therapy in newly diagnosed Philadelphia chromosome-positive chronic phase chronic myeloid leukemia.高剂量甲磺酸伊马替尼治疗新诊断的费城染色体阳性慢性期慢性髓性白血病。
Blood. 2004 Apr 15;103(8):2873-8. doi: 10.1182/blood-2003-11-3800. Epub 2003 Dec 24.
2
Ocular side-effects associated with imatinib mesylate (Gleevec).与甲磺酸伊马替尼（格列卫）相关的眼部副作用。
J Ocul Pharmacol Ther. 2003 Aug;19(4):371-5. doi: 10.1089/108076803322279426.
3
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.
现代抗癌药物的神经眼科并发症。
Graefes Arch Clin Exp Ophthalmol. 2024 Jul;262(7):2269-2281. doi: 10.1007/s00417-023-06350-4. Epub 2024 Feb 12.
4
Probable ponatinib-induced papilledema in a patient with acute lymphocytic leukemia.一名急性淋巴细胞白血病患者可能由波纳替尼引起的视乳头水肿。
Am J Ophthalmol Case Rep. 2023 Oct 6;32:101933. doi: 10.1016/j.ajoc.2023.101933. eCollection 2023 Dec.
5
Targeted Cancer Therapy and Its Ophthalmic Side Effects: A Review.靶向癌症治疗及其眼部副作用：综述
J Immunother Precis Oncol. 2021 Feb 25;4(1):6-15. doi: 10.36401/JIPO-20-21. eCollection 2021 Feb.
6
Ocular Toxicity of Targeted Anticancer Agents.靶向抗癌药物的眼部毒性。
Drugs. 2021 May;81(7):771-823. doi: 10.1007/s40265-021-01507-z. Epub 2021 Mar 31.
7
Optic neuropathy in the context of leukemia or lymphoma: diagnostic approach to a neuro-oncologic emergency.白血病或淋巴瘤相关的视神经病变：神经肿瘤急症的诊断方法
Neurooncol Pract. 2017 Mar;4(1):60-66. doi: 10.1093/nop/npw006. Epub 2016 Dec 9.
8
Chinese consensus on management of tyrosine kinase inhibitor-associated side effects in gastrointestinal stromal tumors.中国胃肠间质瘤酪氨酸激酶抑制剂相关不良反应管理专家共识。
World J Gastroenterol. 2018 Dec 14;24(46):5189-5202. doi: 10.3748/wjg.v24.i46.5189.
9
Neuro-ophthalmic side effects of molecularly targeted cancer drugs.分子靶向抗癌药物的神经眼科副作用。
Eye (Lond). 2018 Feb;32(2):287-301. doi: 10.1038/eye.2017.222. Epub 2017 Oct 20.
10
European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia.欧洲白血病网关于慢性髓性白血病治疗管理及不良事件避免的建议
Leukemia. 2016 Aug;30(8):1648-71. doi: 10.1038/leu.2016.104. Epub 2016 Apr 28.
伊马替尼与干扰素和小剂量阿糖胞苷治疗新诊断慢性期慢性髓性白血病的比较
N Engl J Med. 2003 Mar 13;348(11):994-1004. doi: 10.1056/NEJMoa022457.